The influence of interleukin-4 on transendothelial transport of low-density lipoproteins

Abstract

BACKGROUND: Cytokines are important participants in the atherosclerotic process. The product of T-helpers and mast cells, interleukin-4, causes activation of endothelial cells and induces polarization of macrophages into anti-inflammatory M2 phenotype.

AIM: The aim was to study the influence of interleukin-4 on the activation of transendothelial transport of low-density lipoproteins.

MATERIALS AND METHODS: Low-density lipoproteins transendothelial transport was evaluated in a two-chamber model on a monolayer of human endothelial cell line EA.hy926. For that, 200 mkg/ml of low-density lipoproteins, and 1, or 10, or 100 ng/ml of interleukin-4, or 10, or 50 ng/ml of interleukin-6, or 50 ng/ml of tumor necrosis factor, or 10 ng/ml of interleukin-4 and 50 ng/ml of tumor necrosis factor, or a phosphate buffer saline were added to the cells on 24 h. The integrity of endothelial monolayer was controlled by the passage through 1 mkg/ml of fluorescein Na. The levels of mRNA and proteins in the cells were determined by reverse transcription polymerase chain reaction and Western blotting, the activity of matrix metalloproteinases-1, -2 and -9 in the culture medium — by zymography, interleukin-6 and -8 concentrations — by enzyme-linked immunosorbent assay.

RESULTS: Interleukin-4 had no effect on the passage of low-density lipoproteins through the monolayer of endothelial cells in basal and tumor necrosis factor stimulation conditions. At the same time, interleukin-4 suppressed interleukin-8 secretion by cells and increased their production of interleukin-6. The latter also did not cause the changes in the permeability of endothelial monolayer. In addition, interleukin-4 did not affect the expression of CAV, SCARB1, ACVRL1 genes, encoding proteins involved in low-density lipoproteins transendothelial transport. An addition of interleukin-4 or -6 to the cells did not change the activity of the matrix metalloproteinases.

CONCLUSIONS: Interleukin-4 does not affect the transendothelial transport of low-density lipoproteins, while modulating the production of other cytokines by endothelial cells. In the future, it is necessary to establish the effect of a wider range of cytokines produced by intimal cells on low-density lipoproteins transendothelial transport, as well as to clarify the molecular mechanisms of influence of tumor necrosis factor on this process in order to identify new targets for atherosclerosis therapy.

Keywords

interleukin-4 / interleukin-6 / transendothelial transport / low-density lipoproteins / atherosclerosis

References

[1] Jia X, Liu Z, Wang Y, et al. Serum amyloid A and interleukin-1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway. Atherosclerosis. 2023;375:87–97. doi: 10.1016/j.atherosclerosis.2023.03.004

[2] Jia X., Liu Z., Wang Y. et al. Serum amyloid A and interleukin-1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway // Atherosclerosis. 2023. Vol. 375. P. 87–97. doi: 10.1016/j.atherosclerosis.2023.03.004

[3] Nazarov PG, Maltseva ON, Tanyanskiy DA, et al. Mast cells and control of transendothelial transport: the role of histamine. Cell Tiss Biol. 2021;15:402–408. EDN: IFYFXQ doi: 10.1134/S1990519X21040052

[4] Назаров П.Г., Мальцева О.Н., Танянский Д.А. и др. Тучные клетки и контроль трансэндотелиального транспорта. Роль гистамина // Цитология, 2021, Т. 63, № 2, С. 156–162. EDN: BOZYCH doi: 10.31857/S0041377121020061

[5] Kassem KM, Ali M, Rhaleb NE. Interleukin 4: its role in hypertension, atherosclerosis, valvular, and nonvalvular cardiovascular diseases. J Cardiovasc Pharmacol Ther. 2020;25:7–14. doi: 10.1177/1074248419868699

[6] Kassem K.M., Ali M., Rhaleb N.E. Interleukin 4: its role in hypertension, atherosclerosis, valvular, and nonvalvular cardiovascular diseases // J Cardiovasc Pharmacol Ther. 2020. Vol. 25. P. 7–14. doi: 10.1177/1074248419868699

[7] Tanyanskiy DA, Maltseva ON, Trulioff AS, et al. The influence of adiponectin on transport of low-density lipoproteins through human endothelial cell monolayer in vitro. Bull Exp Biol Med. 2023;176:165–169. doi: 10.1007/s10517-024-05988-2

[8] Tanyanskiy D.A., Maltseva O.N., Trulioff A.S., et al. The influence of adiponectin on transport of low-density lipoproteins through human endothelial cell monolayer in vitro // Bull Exp Biol Med. 2023. Vol. 176. P. 165–169. doi: 10.1007/s10517-024-05988-2

[9] Jang E, Robert J, Rohrer L, et al. Transendothelial transport of lipoproteins. Atherosclerosis. 2020;315:111–125. doi: 10.1016/j.atherosclerosis.2020.09.020

[10] Jang E., Robert J., Rohrer L., et al. Transendothelial transport of lipoproteins // Atherosclerosis. 2020. Vol. 315. P. 111–125. doi: 10.1016/j.atherosclerosis.2020.09.020

[11] Cancel LM, Ebong EE, Mensah S, et al. Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model. Atherosclerosis. 2016;252:136–146. doi: 10.1016/j.atherosclerosis.2016.07.930

[12] Cancel L.M., Ebong E.E., Mensah S., et al. Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model // Atherosclerosis. 2016. Vol. 252. P. 136–146. doi: 10.1016/j.atherosclerosis.2016.07.930

[13] Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6:315–325. doi: 10.1016/s1074-7613(00)80334-9

[14] Romano M., Sironi M., Toniatti C., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment // Immunity. 1997. Vol. 6. P. 315–325. doi: 10.1016/s1074-7613(00)80334-9

[15] Alsaffar H, Martino N, Garrett JP, Adam AP. Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis. Am J Physiol Cell Physiol. 2018;314:C589–C602. doi: 10.1152/ajpcell.00235.2017

[16] Alsaffar H., Martino N., Garrett J.P., Adam A.P. Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis // Am J Physiol Cell Physiol. 2018. Vol. 314. P. C589–C602. doi: 10.1152/ajpcell.00235.2017

RIGHTS & PERMISSIONS

Eco-Vector